There are 134 resources available
Targeting folate receptor
Presenter: Kathleen Moore
Session: Expanding our therapeutic armamentarium: ADCs in the ovarian cancer field
Resources:
Slides
Webcast
Targeting NAPI2B
Presenter: Jose Alejandro Perez Fidalgo
Session: Expanding our therapeutic armamentarium: ADCs in the ovarian cancer field
Resources:
Slides
Webcast
Improving our learning curve on ADC toxicity
Presenter: Frederik Marmé
Session: Expanding our therapeutic armamentarium: ADCs in the ovarian cancer field
Resources:
Slides
Webcast
Q&A and discussion
Session: Expanding our therapeutic armamentarium: ADCs in the ovarian cancer field
Resources:
Webcast
Insights in the biology of ovarian cancer: The neglected pathways
Presenter: Frederik Marmé
Session: ESMO Colloquium supported by ImmunoGen - Platinum-resistant ovarian cancer: Biological pathways, resistance mechanisms and novel treatment options
Resources:
Slides
Webcast
A clinical case of a patient with platinum-resistant ovarian cancer: Resistance mechanisms and state-of-the-art treatment options for patients who are not eligible for platinum-based therapies
Presenter: Nicoletta Colombo
Session: ESMO Colloquium supported by ImmunoGen - Platinum-resistant ovarian cancer: Biological pathways, resistance mechanisms and novel treatment options
Resources:
Slides
Webcast
The promise of antibody drug conjugates (ADCs) in ovarian cancer: Mechanisms of action and emerging therapeutics
Presenter: Toon Van Gorp
Session: ESMO Colloquium supported by ImmunoGen - Platinum-resistant ovarian cancer: Biological pathways, resistance mechanisms and novel treatment options
Resources:
Slides
Webcast
A clinical case of a patient on anti-folate receptor ADC: Efficacy and safety data from folate receptor targeting in registrational trials
Presenter: Kathleen Moore
Session: ESMO Colloquium supported by ImmunoGen - Platinum-resistant ovarian cancer: Biological pathways, resistance mechanisms and novel treatment options
Resources:
Slides
Webcast
Q&A, discussion and concluding remarks
Presenter: Nicoletta Colombo
Session: ESMO Colloquium supported by ImmunoGen - Platinum-resistant ovarian cancer: Biological pathways, resistance mechanisms and novel treatment options
Resources:
Webcast
Introduction and first vote
Presenter: Rebecca Kristeleit
Session: Is FIGO 2023 classification ready for prime time?
Resources:
Slides
Webcast